查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095114

吸入式一氧化氮輸送系統市場：全球預測，2026-2032年

Inhaled Nitric Oxide Delivery Systems Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，吸入式一氧化氮輸送系統市場將成長至 5.6829 億美元，複合年成長率為 6.34%。

主要市場統計數據
基準年 2025 3.6939億美元
預計年份：2026年 3.9196億美元
預測年份 2032 5.6829億美元
複合年成長率 (%) 6.34%

吸入式一氧化氮輸送系統是一種專門的醫療技術，用於透過人工呼吸器、麻醉管路、高流量氧氣鼻管和相關呼吸支援介面輸送一氧化氮氣體。臨床上，吸入式一氧化氮因其選擇性肺血管擴張作用而備受重視。在正確給藥和監測的情況下，它有助於改善氧合併降低肺血管阻力，而不會引起全身血管擴張。其已確立的適應症包括足月和近足月新生兒的低氧性呼吸衰竭伴隨肺動脈高壓，但醫院和學術機構仍在繼續評估其在急性呼吸窘迫症候群、手術全期肺動脈高壓、心血管手術、器官移植和複雜重症監護路徑中的應用。

該行業受嚴格的安全要求約束，要求以受控濃度供應一氧化氮，同時持續監測一氧化氮、二氧化氮和氧氣濃度。劑量準確性、警報性能、設備相容性、氣瓶物流、人員培訓和法規遵循仍然是採購和臨床部署的核心標準。隨著呼吸照護向更網路化、攜帶式和主導的系統轉變，對更安全的工作流程、與重症監護基礎設施的互通性以及在高風險護理中基於循證醫學的管理的需求日益成長，並影響著市場需求。

吸入式一氧化氮傳遞領域的變革性變化

隨著醫院的採購模式從以設備為中心轉向整合式呼吸治療體系，吸入式一氧化氮輸送系統正經歷重大變革。現代系統需要能夠適應多種通氣模式，即使在流速快速變化的情況下也能保持穩定的劑量，並提供具有清晰警報邏輯的持續監測。這在新生兒加護病房、加護病房和成人加護病房等環境中尤其重要，因為即使兒童濃度出現輕微波動也可能影響病人安全。

人工智慧對吸入一氧化氮療法的累積影響

人工智慧 (AI) 正透過決策支援、預測分析、警報最佳化和工作流程自動化，開始影響吸入式一氧化氮輸送系統。在重症監護環境中，AI 驅動的呼吸系統護理平台會分析人工呼吸器參數、氧合趨勢、血流動力學數據和血氣分析結果，以幫助識別需要進一步評估肺動脈高壓或難治性低氧血症的患者。雖然 AI 不會取代臨床判斷，但它可以幫助更早發現病情惡化，並更有效地遵循治療方案。

亞太地區、歐洲、北美、拉丁美洲以及中東和非洲的關鍵區域洞察

亞太地區正發展成為吸入式一氧化氮輸送系統的重要戰略區域，這主要得益於新生兒重症監護能力的提升、三級醫療機構投資的增加，以及中國、印度、日本、韓國和澳洲等國對呼吸衰竭管理日益成長的關注。該地區大規模的新生兒群體、先進機械呼吸系統護理的普及以及兒童和心臟重症監護專科服務的增加，都支撐著該地區的臨床需求。部署趨勢各不相同：日本、韓國和澳洲等醫療體係成熟的國家優先考慮監管合規和設備整合，而新興醫療體系則優先考慮可及性、可負擔性和基礎設施建設。

北約、七國集團、金磚國家、歐盟、東協和海灣合作理事會等關鍵集團的分析

東南亞國協在加強新生兒和重症監護能力方面取得了進展，吸入一氧化氮療法的引入在先進的都市區醫院和私立三級醫療網路中尤為突出。該地區的優先事項包括經濟高效的設備、呼吸治療師培訓、可靠的氣體供應以及覆蓋地域分散的醫療保健系統的服務支援。海灣合作理事會（GCC）國家擁有先進的醫院基礎設施、三級醫療專科以及對國際臨床標準的持續投入，這為在新生兒、兒童、心臟科和重症監護室引入先進的一氧化氮吸入系統提供了支持。

主要吸入式一氧化氮給藥系統市場的關鍵國家特定洞察

美國擁有世界上最完善的吸入式一氧化氮輸送系統之一，這得益於先進的新生兒加護病房、兒童醫院、成人重症監護中心以及詳盡的設施規程。加拿大也重視安全性、實證實踐以及各省醫療保健系統內公平的醫療服務，儘管區域因素可能會影響偏遠地區的醫療服務可近性。在墨西哥和巴西，吸入式一氧化氮的可近性正在擴大，尤其是在大型醫院和專科醫療中心，這些機構在新生兒護理、心臟外科和重症監護方面的基礎設施日益完善。然而，更廣泛的可及性取決於採購能力和臨床訓練水準。

為行業領導者提供的實用建議

產業領導者應優先考慮臨床安全、互通性和基於實證醫學的價值創造。供氣系統必須在所有通氣模式下提供精確的劑量，確保可靠的一氧化氮和二氧化氮監測、直覺的警報功能，並與新生兒、兒童和成人呼吸管路相容。產品策略應著重於降低治療設定的複雜性、提高便攜性、實現安全的資料收集，並支援醫院工作流程中的標準化文件記錄。

調查方法

本執行摘要採用結構化的二手研究途徑編寫，重點在於檢驗的臨床、監管和產業相關資訊來源。該調查方法包括對同行評審的醫學文獻、臨床實踐指南、監管指示、醫院呼吸護理標準、醫用氣體安全要求、新生兒和重症監護方案以及公開的醫療保健系統文件的審查。重點關注適應症、給藥安全性、監測要求、工作流程整合和區域部署條件等方面的證據。

結論

吸入式一氧化氮輸送系統在高級呼吸護理和新生兒護理中發揮著至關重要的作用，它能夠為某些重症患者實現可控的肺血管擴張。該行業正朝著更安全、更協調、更有效率的平台發展，以支持精準給藥、持續監測、標準化方案和更完善的文件記錄。在擁有完善的重症監護基礎設施、訓練有素的呼吸照護團隊、醫用氣體供應鏈和監管體系的地區，該系統的部署最為成熟；而新興地區則繼續關注可及性、可負擔性和醫療服務提供者的準備。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 吸入式一氧化氮輸送系統市場：依產品類型分類

  • 可攜式一氧化氮吸入輸送系統
    • 電池供電系統
    • 緊湊型交通系統
    • 救護車回應系統
  • 固定式吸入一氧化氮輸送系統
    • 重症監護系統
    • 新生兒加護系統
    • 兒科重症監護系統
    • 手術室系統
  • 整合式人工呼吸器系統
    • 整合式人工呼吸器
    • CPAP一體機
  • 獨立交付系統
    • 汽缸式系統
    • 盒式系統

第8章 吸入式一氧化氮輸送系統市場：依技術分類

  • 汽缸技術
  • 電化學一氧化氮發生技術
    • 等離子體脈衝發生方法
    • 化學生產方法
  • 數位交付技術
    • 自動加藥控制
    • 封閉回路型交付
  • 人工管理技術

第9章 吸入式一氧化氮輸送系統市場：依病患小組分類

  • 新生
  • 兒童
  • 成人

第10章 吸入式一氧化氮輸送系統市場：依給藥方式分類

  • 持續管理
  • 間歇給藥

第11章 吸入式一氧化氮輸送系統市場：依應用分類

  • 新生兒缺氧性呼吸衰竭
  • 急性呼吸窘迫症候群
  • 肺動脈高壓
  • 心臟外科手術
  • 器官移植

第12章 吸入式一氧化氮輸送系統市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 居家照護環境
  • 醫院
  • 急診中心

第13章 吸入式一氧化氮輸送系統市場：依通路分類

  • 離線
  • 線上

第14章 吸入式一氧化氮輸送系統市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章 吸入式一氧化氮輸送系統市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第16章 吸入式一氧化氮輸送系統市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Air Liquide SA
  • Beyond Air Inc.
  • BOC Ltd.
  • Coregas Pty Ltd.
  • EKU Elektronik GmbH
  • Getinge AB
  • Gulf Cryo
  • International Biomedical Ltd.
  • Linde plc
  • Mallinckrodt plc
  • Merck KGaA
  • Messer Group GmbH
  • NIOX Group plc
  • Norco Inc.
  • Perma Pure LLC
  • Praxair Inc.
  • SOL Group
  • VERO Biotech LLC
Product Code: MRR-563BF1FCFB8B

The Inhaled Nitric Oxide Delivery Systems Market is projected to grow by USD 568.29 million at a CAGR of 6.34% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 369.39 million
Estimated Year [2026] USD 391.96 million
Forecast Year [2032] USD 568.29 million
CAGR (%) 6.34%

Inhaled nitric oxide delivery systems are specialized medical technologies used to administer nitric oxide gas through ventilators, anesthesia circuits, high-flow nasal cannula, and related respiratory support interfaces. Clinically, inhaled nitric oxide is valued for its selective pulmonary vasodilatory effect, helping improve oxygenation and reduce pulmonary vascular resistance without causing systemic vasodilation when appropriately delivered and monitored. Its established use includes term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension, while hospitals and academic centers continue to evaluate applications across acute respiratory distress syndrome, perioperative pulmonary hypertension, cardiac surgery, transplant care, and complex critical care pathways.

The industry is shaped by strict safety requirements because nitric oxide must be delivered at controlled concentrations while continuously monitoring nitric oxide, nitrogen dioxide, and oxygen levels. Delivery accuracy, alarm performance, device compatibility, cylinder logistics, staff training, and regulatory compliance remain central purchasing and clinical adoption criteria. As respiratory care moves toward more connected, portable, and protocol-driven systems, demand is increasingly influenced by the need for safer workflows, interoperability with intensive care infrastructure, and evidence-based stewardship of high-acuity therapies.

Transformative Shifts in the Inhaled Nitric Oxide Delivery Landscape

The inhaled nitric oxide delivery systems landscape is undergoing a significant transformation as hospitals shift from device-centric purchasing toward integrated respiratory therapy ecosystems. Modern systems are expected to support multiple ventilation modes, maintain consistent dosing during rapid flow changes, and provide continuous monitoring with clear alarm logic. This is especially important in neonatal intensive care units, pediatric intensive care units, operating rooms, and adult critical care environments where small variations in gas concentration can affect patient safety.

Another major shift is the movement toward operational efficiency. Healthcare providers are seeking systems that reduce setup time, simplify circuit changes, and support standardized clinical protocols. The move from traditional cylinder-dependent workflows toward more streamlined supply models, automated documentation, and connected monitoring is improving therapy governance and reducing preventable errors. Regulatory scrutiny is also increasing around gas purity, nitrogen dioxide exposure limits, device maintenance, and post-market performance, creating stronger demand for validated delivery systems and robust training programs.

Clinical practice is also evolving. While neonatal hypoxic respiratory failure associated with pulmonary hypertension remains a key evidence-supported indication in many jurisdictions, clinicians are using increasingly disciplined approaches in off-label and investigational settings. This trend is strengthening the importance of patient selection criteria, response assessment, weaning protocols, and multidisciplinary oversight to ensure appropriate use of inhaled nitric oxide therapy.

Cumulative Impact of AI on Inhaled Nitric Oxide Therapy

Artificial intelligence is beginning to influence inhaled nitric oxide delivery systems through decision support, predictive analytics, alarm optimization, and workflow automation. In critical care, AI-enabled respiratory platforms can help analyze ventilator parameters, oxygenation trends, hemodynamic data, and blood gas results to identify patients who may require closer assessment for pulmonary hypertension or refractory hypoxemia. While AI does not replace clinical judgment, it can support faster recognition of deterioration and more consistent protocol adherence.

The cumulative impact of AI is most visible in monitoring and operations. Intelligent algorithms can assist with anomaly detection, identify unusual dosing patterns, reduce nuisance alarms, and support preventive maintenance by analyzing device performance data. When integrated with electronic health records and respiratory care documentation, AI can help standardize dose titration records, weaning timelines, and response evaluations. This is particularly relevant for high-acuity settings where therapy decisions must be traceable, auditable, and aligned with institutional policies.

AI also has potential to improve stewardship of inhaled nitric oxide by helping clinicians evaluate response windows and avoid prolonged use when clinical benefit is not demonstrated. However, adoption depends on validated datasets, transparent algorithms, cybersecurity safeguards, and regulatory oversight. The most credible AI applications will be those that enhance safety, documentation, and clinical consistency rather than making autonomous treatment decisions.

Key Regional Insights Across Asia-Pacific, Europe, North America, Latin America, Middle East, and Africa

Asia-Pacific is advancing as a strategically important region for inhaled nitric oxide delivery systems due to expanding neonatal intensive care capacity, rising investment in tertiary hospitals, and increasing attention to respiratory failure management in countries such as China, India, Japan, South Korea, and Australia. The region's clinical demand is supported by large birth cohorts, improving access to advanced ventilatory care, and growing availability of specialized pediatric and cardiac critical care services. Adoption patterns vary widely, with mature systems in Japan, South Korea, and Australia emphasizing regulatory compliance and device integration, while emerging health systems prioritize access, affordability, and infrastructure development.

North America remains a highly protocol-driven region, supported by advanced neonatal and pediatric intensive care networks, established respiratory therapy departments, and rigorous safety expectations for medical gas administration. Clinical use is closely tied to hospital guidelines, payer review, and evidence-based utilization management. Latin America demonstrates increasing uptake in leading urban hospitals, particularly where neonatal intensive care and cardiac surgical capabilities are expanding, though access remains uneven due to budget constraints, distribution complexity, and training needs.

Europe is characterized by strong regulatory oversight, structured hospital procurement, and emphasis on clinical evidence, device quality, and environmental and occupational safety standards. Western European health systems generally show broader access to advanced delivery infrastructure, while parts of Central and Eastern Europe continue to develop specialized capacity. The Middle East is investing in high-acuity hospital infrastructure, especially in tertiary and quaternary care centers, creating opportunities for advanced respiratory technologies. Africa presents a more varied landscape, where inhaled nitric oxide delivery remains concentrated in higher-resource hospitals and specialized centers, with broader adoption constrained by equipment availability, medical gas logistics, workforce training, and critical care infrastructure.

Key Group Insights Across NATO, G7, BRICS, European Union, ASEAN, and GCC

ASEAN countries are strengthening neonatal and critical care capabilities, with inhaled nitric oxide delivery adoption most visible in advanced urban hospitals and private tertiary care networks. Regional priorities include cost-efficient equipment, respiratory therapist training, reliable gas supply, and service support across geographically diverse healthcare systems. The GCC is distinguished by sustained investment in advanced hospital infrastructure, tertiary care specialization, and international clinical standards, supporting adoption of sophisticated inhaled nitric oxide delivery systems in neonatal, pediatric, cardiac, and intensive care settings.

The European Union reflects a highly regulated environment in which medical device conformity, clinical evidence, procurement transparency, and patient safety governance shape adoption. Hospitals in the EU prioritize interoperability, traceable documentation, and compliance with medical gas and device performance standards. BRICS countries present a diverse growth environment: China and India are expanding advanced hospital capacity at scale, Brazil and South Africa show demand concentrated in large urban referral centers, and Russia maintains a focus on specialist hospital networks and domestic healthcare resilience.

G7 countries generally represent mature clinical environments with established intensive care infrastructure, strong regulatory systems, and high expectations for safety, training, and documentation. In these countries, differentiation is increasingly tied to workflow efficiency, connected monitoring, and evidence-supported utilization. NATO member countries overlap significantly with advanced European and North American health systems, where military and civilian preparedness considerations reinforce the importance of resilient respiratory care infrastructure, dependable medical gas logistics, and standardized critical care protocols.

Key Country Insights for Major Inhaled Nitric Oxide Delivery System Markets

The United States has one of the most structured environments for inhaled nitric oxide delivery systems, supported by advanced neonatal intensive care units, pediatric hospitals, adult critical care centers, and detailed institutional protocols. Canada shows similar emphasis on safety, evidence-based practice, and equitable access across provincial health systems, though geography can affect availability in remote regions. Mexico and Brazil demonstrate growing use in large hospitals and specialty centers, particularly where neonatal care, cardiac surgery, and intensive care infrastructure are expanding, while broader access depends on procurement capacity and clinical training.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain established critical care and neonatal networks that support regulated use of inhaled nitric oxide therapy. Germany and France emphasize technical standards, hospital quality systems, and specialist care pathways, while the United Kingdom is strongly influenced by national clinical guidance and centralized evaluation processes. Italy and Spain show adoption across public and private hospital systems, with emphasis on neonatal and perioperative critical care. Russia's landscape is shaped by regionalized specialist care, domestic healthcare priorities, and the need for reliable medical technology access across a large geography.

China is expanding advanced respiratory and neonatal care capacity through hospital modernization and specialist center development, creating growing relevance for accurate and scalable nitric oxide delivery infrastructure. India's demand is driven by rising tertiary care investment, large neonatal care needs, and increasing critical care specialization, although affordability and access remain important barriers. Japan and South Korea are mature technology-oriented markets with strong hospital quality standards and interest in precision delivery, monitoring, and integration. Australia combines advanced tertiary care capabilities with strict safety governance, while also addressing access across dispersed populations through regionalized specialist care models.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical safety, interoperability, and evidence-based value creation. Delivery systems must provide accurate dosing across ventilation modes, reliable monitoring of nitric oxide and nitrogen dioxide, intuitive alarms, and compatibility with neonatal, pediatric, and adult respiratory circuits. Product strategies should focus on reducing therapy setup complexity, improving portability, enabling secure data capture, and supporting standardized documentation within hospital workflows.

Manufacturers and healthcare stakeholders should invest in training programs for respiratory therapists, neonatologists, intensivists, anesthesiologists, perfusion teams, biomedical engineers, and nursing staff. Strong education around initiation criteria, monitoring, response assessment, and weaning protocols can improve appropriate utilization and patient safety. Suppliers should also strengthen service networks, cylinder or gas generation logistics where applicable, preventive maintenance programs, and regulatory documentation support.

For long-term competitiveness, leaders should develop connected platforms that support analytics without compromising cybersecurity or clinical accountability. Partnerships with hospitals, academic centers, and standards organizations can help generate real-world evidence, validate workflow improvements, and support responsible AI-enabled decision support. Regional strategies should be tailored to local infrastructure, reimbursement pathways, clinical guidelines, and procurement requirements rather than relying on a uniform global approach.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified clinical, regulatory, and industry-relevant sources. The methodology includes review of peer-reviewed medical literature, clinical practice guidelines, regulatory communications, hospital respiratory care standards, medical gas safety requirements, neonatal and critical care protocols, and publicly available health system documentation. Emphasis is placed on evidence related to indications, delivery safety, monitoring requirements, workflow integration, and regional adoption conditions.

Insights are synthesized through qualitative analysis of technology trends, clinical use patterns, regulatory expectations, and healthcare infrastructure development. Regional, group, and country perspectives are evaluated based on healthcare system maturity, neonatal and intensive care capacity, medical device regulation, procurement behavior, and availability of trained respiratory care professionals. The analysis intentionally avoids market sizing, market share, and forecasting, focusing instead on data-backed industry dynamics, adoption enablers, constraints, and strategic implications.

Quality control involves triangulating findings across multiple credible source categories and excluding unsupported promotional claims. Where clinical applications remain investigational or off-label in some jurisdictions, the summary distinguishes established use from evolving practice considerations and emphasizes the need for local regulatory and clinical governance.

Conclusion

Inhaled nitric oxide delivery systems occupy a critical role in advanced respiratory and neonatal care by enabling controlled pulmonary vasodilation for selected high-acuity patients. The industry is evolving toward safer, more connected, and more workflow-efficient platforms that support accurate dosing, continuous monitoring, standardized protocols, and better documentation. Adoption is strongest where critical care infrastructure, trained respiratory teams, medical gas logistics, and regulatory systems are well developed, while emerging regions continue to focus on access, affordability, and workforce readiness.

Artificial intelligence, connected monitoring, and data-driven stewardship are expected to reshape how hospitals manage inhaled nitric oxide therapy, but the most sustainable progress will come from validated, clinician-supervised tools that improve safety and consistency. Industry leaders that align technology innovation with clinical evidence, regulatory compliance, training, and regional healthcare realities will be best positioned to support the next phase of inhaled nitric oxide delivery in neonatal, pediatric, perioperative, and adult critical care environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Inhaled Nitric Oxide Delivery Systems Market, by Product Type

  • 7.1. Introduction
  • 7.2. Portable Inhaled Nitric Oxide Delivery Systems
    • 7.2.1. Battery Powered Systems
    • 7.2.2. Compact Transport Systems
    • 7.2.3. Ambulance Compatible Systems
  • 7.3. Stationary Inhaled Nitric Oxide Delivery Systems
    • 7.3.1. ICU Systems
    • 7.3.2. NICU Systems
    • 7.3.3. PICU Systems
    • 7.3.4. Operating Room Systems
  • 7.4. Integrated Ventilator Systems
    • 7.4.1. Mechanical Ventilator Integrated
    • 7.4.2. CPAP Integrated
  • 7.5. Standalone Delivery Systems
    • 7.5.1. Cylinder Based Systems
    • 7.5.2. Cartridge Based Systems

8. Inhaled Nitric Oxide Delivery Systems Market, by Technology

  • 8.1. Introduction
  • 8.2. Cylinder Based Technology
  • 8.3. Electric Nitric Oxide Generation Technology
    • 8.3.1. Plasma Pulse Generation
    • 8.3.2. Chemical Generation
  • 8.4. Digital Delivery Technology
    • 8.4.1. Automated Dose Control
    • 8.4.2. Closed Loop Delivery
  • 8.5. Manual Delivery Technology

9. Inhaled Nitric Oxide Delivery Systems Market, by Patient Group

  • 9.1. Introduction
  • 9.2. Neonatal
  • 9.3. Pediatric
  • 9.4. Adult

10. Inhaled Nitric Oxide Delivery Systems Market, by Modality

  • 10.1. Introduction
  • 10.2. Continuous Delivery
  • 10.3. Intermittent Delivery

11. Inhaled Nitric Oxide Delivery Systems Market, by Application

  • 11.1. Introduction
  • 11.2. Neonatal Hypoxic Respiratory Failure
  • 11.3. Acute Respiratory Distress Syndrome
  • 11.4. Pulmonary Hypertension
  • 11.5. Cardiac Surgery
  • 11.6. Organ Transplantation

12. Inhaled Nitric Oxide Delivery Systems Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Clinics
  • 12.4. Homecare Settings
  • 12.5. Hospitals
  • 12.6. Emergency Care Centers

13. Inhaled Nitric Oxide Delivery Systems Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline
  • 13.3. Online

14. Inhaled Nitric Oxide Delivery Systems Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. Europe
  • 14.3. North America
  • 14.4. Latin America
  • 14.5. Africa
  • 14.6. Middle East

15. Inhaled Nitric Oxide Delivery Systems Market, by Group

  • 15.1. NATO
  • 15.2. G7
  • 15.3. BRICS
  • 15.4. European Union
  • 15.5. ASEAN
  • 15.6. GCC

16. Inhaled Nitric Oxide Delivery Systems Market, by Country

  • 16.1. China
  • 16.2. United States
  • 16.3. Japan
  • 16.4. India
  • 16.5. Germany
  • 16.6. United Kingdom
  • 16.7. Australia
  • 16.8. France
  • 16.9. South Korea
  • 16.10. Italy
  • 16.11. Canada
  • 16.12. Russia
  • 16.13. Brazil
  • 16.14. Mexico
  • 16.15. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Air Liquide S.A.
  • 18.2. Beyond Air Inc.
  • 18.3. BOC Ltd.
  • 18.4. Coregas Pty Ltd.
  • 18.5. EKU Elektronik GmbH
  • 18.6. Getinge AB
  • 18.7. Gulf Cryo
  • 18.8. International Biomedical Ltd.
  • 18.9. Linde plc
  • 18.10. Mallinckrodt plc
  • 18.11. Merck KGaA
  • 18.12. Messer Group GmbH
  • 18.13. NIOX Group plc
  • 18.14. Norco Inc.
  • 18.15. Perma Pure LLC
  • 18.16. Praxair Inc.
  • 18.17. SOL Group
  • 18.18. VERO Biotech LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BATTERY POWERED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BATTERY POWERED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BATTERY POWERED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPACT TRANSPORT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPACT TRANSPORT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COMPACT TRANSPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AMBULANCE COMPATIBLE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AMBULANCE COMPATIBLE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AMBULANCE COMPATIBLE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ICU SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ICU SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ICU SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NICU SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NICU SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NICU SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PICU SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PICU SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PICU SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPERATING ROOM SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPERATING ROOM SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPERATING ROOM SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTEGRATED VENTILATOR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTEGRATED VENTILATOR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTEGRATED VENTILATOR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MECHANICAL VENTILATOR INTEGRATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MECHANICAL VENTILATOR INTEGRATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MECHANICAL VENTILATOR INTEGRATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CPAP INTEGRATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CPAP INTEGRATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CPAP INTEGRATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STANDALONE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STANDALONE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STANDALONE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CYLINDER BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CYLINDER BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CYLINDER BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARTRIDGE BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARTRIDGE BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARTRIDGE BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CYLINDER BASED TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CYLINDER BASED TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CYLINDER BASED TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLASMA PULSE GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLASMA PULSE GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLASMA PULSE GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CHEMICAL GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CHEMICAL GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CHEMICAL GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL DELIVERY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED DOSE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED DOSE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED DOSE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CLOSED LOOP DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CLOSED LOOP DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CLOSED LOOP DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MANUAL DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MANUAL DELIVERY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MANUAL DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEONATAL HYPOXIC RESPIRATORY FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEONATAL HYPOXIC RESPIRATORY FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEONATAL HYPOXIC RESPIRATORY FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 235. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 236. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 290. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED VENTILATOR SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 292. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRIC NITRIC OXIDE GENERATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIGITAL DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 297. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STATIONARY INHALED NITRIC OXIDE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA INHALED